Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis.

Hwang, Shen-An; Wilk, Katarzyna M; Budnicka, Monika; Olsen, Margaret; Bangale, Yogesh A; Hunter, Robert L; Kruzel, Marian L; Actor, Jeffrey K

Hwang, Shen-An; Wilk, Katarzyna M; Budnicka, Monika; Olsen, Margaret; Bangale, Yogesh A; Hunter, Robert L; Kruzel, Marian L; Actor, Jeffrey K.

Affiliation

Hwang SA; Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, TX 77030, United States.

Vaccine ; 25(37-38): 6730-43, 2007 Sep 17.

Article in En | MEDLINE | ID: mdl-17698261

Subject(s)

BCG Vaccine/immunology; Lactoferrin/immunology; Mycobacterium tuberculosis/immunology; Mycobacterium tuberculosis/pathogenicity; Animals; Antigens/immunology; Dosage Forms; Female; Immunization, Secondary; Interferon-gamma/genetics; Lung/immunology; Lung/microbiology; Mice; Mice, Inbred C57BL; Organ Specificity/immunology; RNA, Messenger/genetics; Spleen/immunology; Spleen/microbiology; Tumor Necrosis Factor-alpha/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: BCG Vaccine / Lactoferrin / Mycobacterium tuberculosis Limits: Animals Language: En Journal: Vaccine Year: 2007 Document type: Article Affiliation country: United States Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google